3D-printing and the effect on medical costs: a new era?

  • Choonara Y
  • du Toit L
  • Kumar P
 et al. 
  • 3


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


3D-printing (3DP) is the art and science of printing in a new dimension using 3D printers to transform 3D computer aided designs (CAD) into life-changing products. This includes the design of more effective and patient-friendly pharmaceutical products as well as bio-inspired medical devices. It is poised as the next technology revolution for the pharmaceutical and medical-device industries. After decorous implementation scientists in collaboration with CAD designers have produced innovative medical devices ranging from pharmaceutical tablets to surgical transplants of the human face and skull, spinal implants, prosthetics, human organs and other biomaterials. While 3DP may be cost-efficient, a limitation exists in the availability of 3D printable biomaterials for most applications. In addition, the loss of skilled labor in producing medical devices such as prosthetics and other devices may affect developing economies. This review objectively explores the potential growth and impact of 3DP costs in the medical industry.

Author-supplied keywords

  • 3-d printers
  • 3d
  • 3d-printing
  • additive manufacturing
  • bioprinting
  • biotechnology
  • developing economies
  • drug-release
  • fabrication
  • hydrogel scaffolds
  • innovative healthcare
  • medical costs
  • medical device
  • pharmaceuticals
  • spine
  • tablets
  • virtual pharmacies

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Y E Choonara

  • L C du Toit

  • P Kumar

  • P P D Kondiah

  • V Pillay

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free